| Dr Cuong Chi Ho, DDS | |
|
156 W Portal Ave # C, San Francisco, CA 94127-1306 | |
| (415) 564-2200 | |
| (415) 520-6737 |
| Full Name | Dr Cuong Chi Ho |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 156 W Portal Ave # C, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003051541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 57980 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cuong Chi Ho, DDS 156 W Portal Ave # C, San Francisco, CA 94127-1306 Ph: (415) 564-2200 | Dr Cuong Chi Ho, DDS 156 W Portal Ave # C, San Francisco, CA 94127-1306 Ph: (415) 564-2200 |
News Archive
Patients with non-small cell lung cancer treated with preventative brain radiation (called prophylactic cranial irradiation or PCI), significantly decrease their risk of developing brain metastases (cancer spread in the brain) by more than 50 percent (from 18 percent to 8 percent), compared to those who did not receive the treatment, according to a randomized study presented at the plenary session November 2, 2009, at the 51st Annual Meeting of American Society for Radiation Oncology (ASTRO).
In a symposium session on Monday at the XIX International AIDS Conference in Washington, D.C., politicians and public health experts joined Bill & Melinda Gates Foundation Co-Chair Bill Gates for a discussion about improving effectiveness and efficiency in the HIV/AIDS response, the Washington Post reports.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
The U.S. Food and Drug Administration recently approved the first new drug to fight tuberculosis (TB) in more than 40 years, but treatment still takes six months, 200 pills and leaves 40 percent of patients uncured. Thus, new targets are needed. Today in ACS Central Science, researchers report they have identified one such target - a gene that allows the disease to camp out in human immune cells, and is thus essential for the organism's proliferation.
› Verified 1 days ago
Dr. Laila Kafi, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2827 Franklin St, San Francisco, CA 94123 Phone: 415-776-1900 Fax: 415-776-5504 | |
Dr. Ephraim W Aklilu, Dentist Medicare: Not Enrolled in Medicare Practice Location: 58 W Portal Ave # 106, San Francisco, CA 94127 Phone: 510-914-6903 | |
Dr. Kapil Deepak Kirpekar, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2494 Mission St, San Francisco, CA 94110 Phone: 415-873-8225 | |
Dr. Anh T Nguyen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2295 California St Apt 37, San Francisco, CA 94115 Phone: 408-209-4711 | |
Alireza Khoshvaghti, DDS Dentist Medicare: Medicare Enrolled Practice Location: 220 Montgomery St Ste 483, San Francisco, CA 94104 Phone: 415-398-6344 | |
Joseph Yang, MD, DMD, MBE Dentist Medicare: Medicare Enrolled Practice Location: 99 W Portal Ave, San Francisco, CA 94127 Phone: 415-661-6006 |